KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other Accumulated Expenses: 2013-2014

  • Biocryst Pharmaceuticals' Other Accumulated Expenses rose 150.46% to $4.7 million in Q4 2014 from the same period last year, while for Dec 2014 it was $4.7 million, marking a year-over-year increase of 150.46%. This contributed to the annual value of $4.7 million for FY2014, which is 150.46% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Other Accumulated Expenses stood at $4.7 million for Q4 2014, which was up 150.46% from $1.9 million recorded in Q4 2013.
  • Over the past 5 years, Biocryst Pharmaceuticals' Other Accumulated Expenses peaked at $4.7 million during Q4 2014, and registered a low of $1.9 million during Q4 2013.
  • Over the past 2 years, Biocryst Pharmaceuticals' median Other Accumulated Expenses value was $3.3 million (recorded in 2013), while the average stood at $3.3 million.
  • Data for Biocryst Pharmaceuticals' Other Accumulated Expenses shows a peak YoY skyrocketed of 150.46% (in 2014) over the last 5 years.
  • Quarterly analysis of 2 years shows Biocryst Pharmaceuticals' Other Accumulated Expenses stood at $1.9 million in 2013, then surged by 150.46% to $4.7 million in 2014.